(Q44915664)

English

Topotecan in patients with advanced neuroendocrine tumors: a phase II study with significant hematologic toxicity

scientific article

In more languages
default for all languages
No label defined

No description defined

Statements

Topotecan in patients with advanced neuroendocrine tumors: a phase II study with significant hematologic toxicity (English)

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit